Clinigen Group Plc provided group earnings guidance for the year ended 30 June 2019. The Group expects to report an increase of revenues of at least 19% on a reported basis and constant currency basis compared to last year. Gross profit is expected to have increased by at least 30% on a reported basis and 31% on a constant currency basis. EBITDA growth is expected to have increased ahead of gross profit, in line with the Board's expectations whilst EPS is expected to have increased by at least 15%. The strong growth has been driven primarily by acquisitions with each contributing towards the Group's performance.